Wasdell Group set to open new facility

摘要

The Wasdell Group, an outsourcing partner to companies in the pharmaceutical, medical device and clinical trials industries, has announced the opening of a new facility in Dundalk, Ireland. Set to open in spring 2019, the new site follows a ( 30 million investment. The 90,000 ft2 facility will allow Wasdell to offer quality control import testing for pharma products, as well as a variety of current and novel packaging technologies. It will also boost its storage and distribution services outside of the UK. Moreover, the facility will futureproof the company's operations in the event of a hard Brexit when the UK exits the EU in March 2019. By giving Wasdell a foothold in Ireland, it will be able to carry out EU release testing ensuring continuous supply for customers regardless of the outcome of Brexit negotiations. Martin Tedham, Wasdell Group CEO, said: "With our new facility, we are not only increasing our packaging and analytical testing capacity to better service new and future customers, but with Brexit on the horizon, we are ensuring challenges and costs are minimised by preparing for every eventuality. "Almost 75% of our current turnover is export business and as our customer base is continuing to grow significantly in the US, this facility will allow Wasdell to remain a secure stepping stone into the European market." Building work on the site, which is expected to fully operational by spring 2019, began in August 2018.